ACOG: Similar VTE Risk with Vaginal Ring and Combined Oral Contraceptive

Article

When used under routine conditions, vaginal ring and combined oral contraceptives have similar venous thrombolism risks, according to a prospective, controlled, non-interventional cohort study.

When used under routine conditions, vaginal ring (VR) and combined oral contraceptives (COC) have similar venous thrombolism (VTE) risks, according to a prospective, controlled, non-interventional cohort study.

The “Transantlatntic Active Surveillance on Cardiovascular Safety of NuvaRing” (TASC) included 33,704 subjects from the United States and five European countries, and investigated the risks of short and long-term use of VR and COCs in a population representative of routine use.

One cohort used a VR containing etonogestrel and ethinylestradiol. A second cohort used COCs. All subjects were new users-starters, switchers or restarters-and were recruited by 1,661 study centers with a two- to four-year follow-up. Self-reported outcomes were verified by health care professionals. Analysis adjustments were made using the Cox regression model.

Results, presented by Juergen Dinger, MD, PhD, of the Berlin Center for Epidemiology at the American Congress of Obstetricians and Gynecologists’ Annual Clinical Meeting, are based on 46,806 woman-years (WY) of follow-up. Comprehensive measures were taken to ensure a low follow-up loss. Overall, 34 confirmed VTEs occurred in current users of VR or COCs.

The overall VTE incidence for users of hormonal contraceptives is 9.4/10,000 WY, respectively (95% confidence interval [CI], 6.5-13.1). For VR and COCs, the VTE incidence is 8.8 and 9.9/10,000 WY, respectively.

The crude hazard ratio for VR vs. COCs is 0.9 (95% CI: 6.5-13.1). After making allowances for age, body mass index, duration of current VR/COC use and family history of VTE, the adjusted HR is 0.8 (95% CI: 0.4-1.6).

Results indicate a similar risk of VTE for users of VR or COC under conditions of routine use.


 

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Maria Gallo, PhD, discusses high attendance at crisis pregnancy centers | Image Credit: © x.com.
Ivie Odiase, MD
Susan Khalil, MD
Expert discussions from the 2025 ACOG meeting | Image Credit: © stevengaertner - © stevengaertner - stock.adobe.com.
Trina Mansour, MD
Negative pressure wound therapy reduces c-section infections and costs | Image Credit: doctors.valleyhealth.com.
Amy Valent DO, MCR, highlights new tech for prenatal diabetes management | Image Credit: linkedin.com.
Lisa Bayer, MD, MPH
Megan Wasson, DO, FACOG
Related Content
© 2025 MJH Life Sciences

All rights reserved.